| FEMALE | |
|---|---|
| Right | |
| C50.211 | Malignant neoplasm of upper-inner quadrant, right female breast |
| C50.311 | Malignant neoplasm of lower-inner quadrant, right female breast |
| C50.411 | Malignant neoplasm of upper-outer quadrant, right female breast |
Malignant neoplasm of upper-inner quadrant of left female breast. C50.212 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM C50.212 became effective on October 1, 2018.
Breast Cancer ICD-10 Code Reference Sheet. FEMALE. Right. C50.011. Malignant neoplasm of nipple and areola, right female breast. C50.111. Malignant neoplasm of central portion, right female breast. C50.211. Malignant neoplasm of upper-inner quadrant, right female breast.
This is not a comprehensive list of ICD-10 codes, but these codes are more commonly used for each cancer site. There are more specific codes available. Please visit cms.gov/medicare-coverage-database/staticpages/icd-10-code-lookup.aspx for a complete list of codes.
there is a single tumor located at the 12, 3, 6, or 9 o’clock position on the breast Code the primary site to C509 when there are multiple tumors (two or more) in at least two quadrants of the breast
C50. 911 - Malignant neoplasm of unspecified site of right female breast | ICD-10-CM.
ICD-10 code C50. 411 for Malignant neoplasm of upper-outer quadrant of right female breast is a medical classification as listed by WHO under the range - Malignant neoplasms .
Malignant neoplasm of unspecified site of unspecified female breast. C50. 919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
51 Secondary malignant neoplasm of bone.
D05. 1 - Intraductal carcinoma in situ of breast | ICD-10-CM.
Z85. 3 - Personal history of malignant neoplasm of breast. ICD-10-CM.
Breast Cancer ICD-10 Code Reference SheetLeftC50.012Malignant neoplasm of nipple and areola, left female breastC50.312Malignant neoplasm of lower-inner quadrant, left female breastC50.412Malignant neoplasm of upper-outer quadrant, left female breastC50.512Malignant neoplasm of lower-outer quadrant, left female breast8 more rows
3: Family history of malignant neoplasm of breast.
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
Another difference is the number of codes: ICD-10-CM has 68,000 codes, while ICD-10-PCS has 87,000 codes.
Antineoplastic drugs are medications used to treat cancer. Other names for antineoplastic drugs are anticancer, chemotherapy, chemo, cytotoxic, or hazardous drugs.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The 2022 edition of ICD-10-CM C50.911 became effective on October 1, 2021.